INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Cipla Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 500087	ISIN Demat INE059A01026	Book Value 397.39	NSE Symbol CIPLA	Dividend Yield (%) 1.07	Market Cap (₹ Cr.) 121,259.61	P/E 23.47	EPS 63.96	Face Value 2

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	19,044.85	16,574.34	14,345.34	15,380.82	11,302.71
Sale of Products	16,111.45	15,924.20	14,690.14	15,052.48	11,060.17
Sale of Services	0.00	0.00	0.00	0.00	0.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	2,933.40	2,133.20	1,271.81	328.34	290.56
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	19,044.85	16,574.34	14,345.34	15,380.82	11,302.71
Other Income	984.72	1,070.66	456.79	666.70	230.28
Total Revenue	20,029.57	17,645.00	14,802.13	16,047.52	11,532.99
Changes in Inventories	-229.87	104.57	194.32	-541.93	6.41
Cost of Material Consumed	3,642.84	2,617.21	2,746.50	3,616.69	2,249.35
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	2,056.75	2,360.41	1,993.39	2,850.85	1,847.85
Employee Benefits	3,054.87	2,644.21	2,335.69	2,113.78	1,703.58
Total Other Expenses	4,741.82	4,363.79	3,722.55	3,630.20	2,428.11
Manufacturing / Operating Expenses	1,665.18	1,515.13	1,246.06	1,242.13	1,140.67
Administrative and Selling Expenses	2,604.73	2,510.53	2,334.97	2,107.17	1,578.59
Other Expenses	471.91	338.13	141.52	280.90	-291.15
Finance Costs	15.11	20.25	22.27	26.93	45.07
Depreciation and Amortization	573.89	587.59	595.91	546.62	468.62
Total Expenses	13,855.41	12,698.03	11,610.63	12,243.14	8,748.99
Profit Before Exceptional Items and Tax	6,174.16	4,946.97	3,191.50	3,804.38	2,784.00
Exceptional Items Before Tax	294.66	0.00	-185.90	0.00	0.00
Profit Before Extraordinary Items and Tax	6,468.82	4,946.97	3,005.60	3,804.38	2,784.00
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	6,468.82	4,946.97	3,005.60	3,804.38	2,784.00
Taxation	1,311.17	1,232.78	861.54	921.80	739.35
Current Tax	1,360.32	1,226.69	901.63	949.49	756.27
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-49.15	6.09	-40.09	-27.69	-16.92
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	5,157.65	3,714.19	2,144.06	2,882.58	2,044.65
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	363.06	369.41	75.35	423.63
Profit / (Loss) from Discontinuing Operations	0.00	485.17	493.67	0.00	566.66
Tax Expenses of Discontinuing Operations	0.00	-122.11	-124.26	75.35	-143.03
Profit Attributable to Shareholders	5,157.65	4,077.25	2,513.47	2,957.93	2,468.28
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	5,157.65	4,077.25	2,513.47	2,957.93	2,468.28
Earning Per Share - Basic	63.87	50.51	31.15	36.67	30.61
Earning Per Share - Diluted	63.82	50.46	31.12	36.63	30.57
Operation Profit before Depreciation	6,763.16	5,554.81	3,809.68	4,377.93	3,297.69
Operating Profit after Depreciation	6,189.27	4,967.22	3,213.77	3,831.31	2,829.07
Dividend Per Share	16.00	13.00	8.50	5.00	5.00
Dividend Percentage	800.00	650.00	425.00	250.00	250.00
Equity Dividend	1,292.19	1,049.58	686.08	403.41	403.23
Weighted Average Shares - Basic	80.76	80.73	80.70	80.67	80.64
Weighted Average Shares - Diluted	80.82	80.80	80.76	80.74	80.73